Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Ann Richie
Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Changes in Peripheral Blood Lymphocytes in Polycythemia Vera and Essential Thrombocythemia Patients Treated With Pegylated-Interferon Alpha and Correlation With JAK2 V617F Allelic Burden
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Updates in the Management of Polycythemia Vera and Essential Thrombocythemia
Therapeutic Advances in Hematology
Hematology
Clonal Analyses Reveal Associations of JAK2V617F Homozygosity With Hematologic Features, Age and Gender in Polycythemia Vera and Essential Thrombocythemia
Haematologica
Hematology
Myocardial Infarction as a Thrombotic Complication of Essential Thrombocythemia and Polycythemia Vera
Anatolian journal of cardiology
Cardiovascular Medicine
Cardiology
Polycythemia Vera and Essential Thrombocythemia: 2019 Update on Diagnosis, Risk-Stratification and Management
American Journal of Hematology
Hematology
Induction Pegylated Interferon Alfa-2a and High Dose Ribavirin Do Not Increase SVR in Heavy Patients With HCV Genotype 1 and High Viral Loads
Gastroenterology
Hepatology
Gastroenterology
Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study
Hepatitis Monthly
Hepatology
Infectious Diseases
Vitamin D Deficiency and Janus Kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera
Malaysian Journal of Medical Sciences
Medicine
Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
